E-80 | The Heart-Lung Connection: Exploring the Relationship Between Concurrent Pulmonary Hypertension and Post-TAVR Outcomes

CIs) were calculated using fixed-effects models, and heterogeneity was assessed via I 2 .Results: TAVI patients were older (mean age: 82.6 vs. 79.3years) and had more comorbidities.30-day mortality was comparable (OR: 0.76, 95% CI: 0.54 -1.07, p 0.12).TAVI showed lower 1-year mortality (OR: 0.80, 95% CI: 0.66-0.96,p 0.02), while 5-year outcomes were similar (OR: 1.12, 95% CI: 0.93-1.36,p 0.23).At 6 years, mortality remained comparable (OR: 1.21, 95% CI: 0.75-1.97,p 0.43).Low heterogeneity (I 2 13%) ensured consistency.Conclusions: These findings highlight the comparable long-term mortality outcomes between TAVI and SAVR, validating TAVI as a minimally invasive alternative in high-risk patients.Continued advancements in procedural technology and patient stratification strategies are essential to further optimize outcomes.

Authors

Institutions

Publication Details

Journal
Journal of the Society for Cardiovascular Angiography & Interventions
Published
2025-05-01
DOI
https://doi.org/10.1016/j.jscai.2025.103341
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

E-80 | The Heart-Lung Connection: Exploring the Relationship Between Concurrent Pulmonary Hypertension and Post-TAVR Outcomes

Manisha Singam, Julia Yu, Aleyah Hattab, Andrew K. Carlson et al.
Journal of the Society for Cardiovascular Angiography & Interventions
Pulmonary Hypertension Research and Treatments
article

E-80 | The Heart-Lung Connection: Exploring the Relationship Between Concurrent Pulmonary Hypertension and Post-TAVR Outcomes

Manisha Singam, Julia Yu, Aleyah Hattab, Andrew K. Carlson, Jennifer Dau, Suhas Seshadri, Edward Salem, Neil Gupta, Adhir Shroff, David Tiu, Aanya Roy, A. L. Arora, Chukwunonyelum Uche, Simon Liu, Atreya Mishra, Pal Shah, Vicki Groo, Rohan Bhattaram, C. Ene, Kayla Torres, Stephanie Dwyer, Victor Qiao, Jon Silberstein, Siddharth Bhayani, Samer Habeel, Rashmi Rana, Daniel Tiu, Mariam Ismail, Laura Navarro, Runze Zhang, Sudarshan Sahgal, Raghav Matta, Romani Wahba, Azmer Khan, Swetha Kalagara, Jesse Balami, Sridhar Chaganti, Bayan Hammad, Zachary Natsheh, Vidur Gurbuxani, Arvind Draffen, Humaam Sufyaan
article en

Abstract

CIs) were calculated using fixed-effects models, and heterogeneity was assessed via I 2 .Results: TAVI patients were older (mean age: 82.6 vs. 79.3years) and had more comorbidities.30-day mortality was comparable (OR: 0.76, 95% CI: 0.54 -1.07, p 0.12).TAVI showed lower 1-year mortality (OR: 0.80, 95% CI: 0.66-0.96,p 0.02), while 5-year outcomes were similar (OR: 1.12, 95% CI: 0.93-1.36,p 0.23).At 6 years, mortality remained comparable (OR: 1.21, 95% CI: 0.75-1.97,p 0.43).Low heterogeneity (I 2 13%) ensured consistency.Conclusions: These findings highlight the comparable long-term mortality outcomes between TAVI and SAVR, validating TAVI as a minimally invasive alternative in high-risk patients.Continued advancements in procedural technology and patient stratification strategies are essential to further optimize outcomes.

Journal of the Society for Cardiovascular Angiography & InterventionsVol. 4(5)
Illinois College (US), University of Illinois Chicago (US), University of Chicago (US), Northwestern College - Illinois (US), Aurora University (US)
Openalex Percentile: Top 86%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.